Literature DB >> 3017187

Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis.

Z Argov, D Soffer, S Eisenberg, Y Zimmerman.   

Abstract

Three siblings with chemically proved cerebrotendinous xanthomatosis presented with typical neurological manifestations of dementia and spinocerebellar disorder. Electrodiagnostic tests revealed demyelinating neuropathy in all three. Sural nerve biopsies showed loss of myelinated large fibers, marked Schwann cell proliferation, and onion bulb formation. Teased-fiber preparations confirmed the occurrence of segmental demyelination and remyelination. We suggest that demyelinating neuropathy is part of the neurological spectrum of cerebrotendinous xanthomatosis and should be considered in the differential diagnosis of a recessively inherited motor and sensory neuropathy.

Entities:  

Mesh:

Year:  1986        PMID: 3017187     DOI: 10.1002/ana.410200115

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.

Authors:  C Cheng-Mayer; C Weiss; D Seto; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid.

Authors:  F Ginanneschi; A Mignarri; M Mondelli; G N Gallus; M Del Puppo; S Giorgi; A Federico; A Rossi; M T Dotti
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

Review 3.  Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.

Authors:  M Donaghy; R H King; R O McKeran; M S Schwartz; P K Thomas
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

4.  Electrophysiological studies in cerebrotendinous xanthomatosis.

Authors:  Y Tokimura; M Kuriyama; K Arimura; J Fujiyama; M Osame
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

5.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis.

Authors:  Shu-Fang Chen; Nai-Wen Tsai; Chung-Chih Chang; Cheng-Hsien Lu; Chi-Ren Huang; Yao-Chung Chuang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2011-05-31       Impact factor: 2.474

7.  Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population.

Authors:  Shu Zhang; Wei Li; Rui Zheng; Bing Zhao; Yongqing Zhang; Dandan Zhao; Cuiping Zhao; Chuanzhu Yan; Yuying Zhao
Journal:  Ann Transl Med       Date:  2020-11

8.  Reconstruction of bilateral tendoachilles with fascia lata graft.

Authors:  Vikas Saxena; Pavan Pradhan; Ashok Yadav; Neeraj Nathani
Journal:  Indian J Orthop       Date:  2013-11       Impact factor: 1.251

9.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.